Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

Raltegravir is a novel human immunodeficiency virus type 1 (HIV-1) integrase inhibitor with potent in vitro activity (95% inhibitory concentration of 31 nM in 50% human serum). This article reports the results of an open-label, sequential, three-period study of healthy subjects. Period 1 involved ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wenning, Larissa A., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Stek, Jon E., Lasseter, Kenneth C., Gottesdiener, Keith M., Chen, Joshua, Teppler, Hedy, Wagner, John A., Stone, Julie A., Iwamoto, Marian
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2008
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533504/
https://ncbi.nlm.nih.gov/pubmed/18625763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00005-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados